How Advanced Imaging Helps Us Diagnose Dry Eye Disease
"I've tried every eye drop, but nothing seems to work."
It's one of the most common things I hear from new patients.
By the time someone arrives at The Dry Eye Suite, they've often spent months—or even years—trying different lubricating eye drops, warm compresses or over-the-counter treatments with little success.
The reason is often surprisingly simple.
You can't effectively treat dry eye until you understand what's causing it.
Dry eye isn't a diagnosis in itself—it's a symptom. And like any symptom, there can be many different underlying causes.
That's why I invested in the Topcon TERA Dry Eye Platform, becoming the first practice in Ireland to introduce this technology. My goal wasn't simply to have the latest equipment; it was to provide patients with a more accurate diagnosis and a treatment plan based on objective clinical findings rather than guesswork.
Dry Eye Isn't Just "Dry Eye"
One of the biggest misconceptions about dry eye disease is that everyone has the same problem.
In reality, dry eye can develop for many different reasons.
Some people don't produce enough tears.
Others produce plenty of tears, but those tears evaporate too quickly because the oil-producing meibomian glands aren't working properly.
Some have significant eyelid inflammation, blepharitis or Demodex.
Others have allergies, autoimmune disease, medication-related dryness or a combination of several different factors.
If we don't identify which type of dry eye you have and why it's happening, treatment often becomes a process of trial and error.
Artificial tears may provide temporary relief, but they won't unblock meibomian glands, improve blink quality or treat eyelid inflammation.
That's why every assessment at The Dry Eye Suite starts with one question:
Why are your eyes dry?
Once we understand the answer, we can recommend the most appropriate treatment for you.
Why Early Diagnosis Matters
One of the most important structures we assess during your appointment is the meibomian glands.
These tiny oil-producing glands sit within your eyelids and produce the outer lipid layer of your tear film. This oily layer slows evaporation and helps keep the surface of the eye comfortable and stable.
In many patients with dry eye disease, these glands gradually become blocked and inflamed. Over time, this can lead to meibomian gland dropout, where the glands shrink and eventually disappear.
Current evidence suggests that once a meibomian gland has undergone complete atrophy, it is unlikely to regenerate. While we can often improve the function of the remaining glands and help slow further deterioration, we cannot simply replace glands that have been lost.
This is one of the reasons I encourage patients not to ignore persistent dry eye symptoms.
The earlier we identify meibomian gland dysfunction, the greater our opportunity to preserve the healthy glands you still have and intervene before irreversible damage occurs.
Why I Chose the Topcon TERA
When I was designing The Dry Eye Suite, I wanted patients to receive a level of assessment that simply wasn't widely available.
The Topcon TERA combines advanced dry eye diagnostics with high-resolution imaging and automated analysis, allowing us to assess multiple aspects of ocular surface health during a single appointment. It follows the latest TFOS DEWS III diagnostic recommendations and provides objective measurements alongside the clinical examination.
The technology is impressive—but what matters most is what it tells us about your eyes.
Seeing the Parts of Dry Eye We Couldn't See Before
Meibography
One of the most valuable features of the TERA is infrared meibography.
Rather than guessing how healthy your meibomian glands are, we can actually visualise them.
This allows us to identify:
Healthy glands
Early gland shortening
Blocked glands
Areas of gland loss
Advanced gland dropout
For many patients, this is the moment everything clicks.
They finally understand why they've been struggling with dry, irritated eyes and why certain treatments are recommended.
Tear Film Stability
The TERA measures Non-Invasive Tear Break-Up Time (NIBUT).
This tells us how long your tear film remains stable after each blink without the need for dye.
If the tear film breaks up too quickly, the surface of the eye becomes exposed, leading to burning, fluctuating vision, irritation and reflex watering.
Lipid Layer Assessment
Not all tears are the same.
The outer oily layer of the tear film plays a vital role in preventing tears from evaporating.
Using patented diffuse white-light imaging, the TERA allows us to assess the quality of this lipid layer and compare it with internationally recognised grading scales.
Blink Analysis
Many people don't blink as completely or as often as they should—particularly when using computers, tablets and smartphones.
The TERA analyses your blink pattern and average blink rate, helping us determine whether incomplete blinking may be contributing to your symptoms.
Tear Volume
The TERA measures tear meniscus height, giving us an indication of how much tear volume is present.
This helps distinguish between patients who aren't producing enough tears and those whose tears are evaporating too quickly.
Ocular Redness & Blepharitis
High-resolution colour imaging allows us to document redness and examine the eyelid margins for signs of blepharitis.
These images can be compared over time, helping us monitor inflammation and your response to treatment using recognised grading systems.
Fluorescein & Lissamine Green Staining
Technology doesn't replace a clinical examination—it enhances it.
Where appropriate, I also use fluorescein and lissamine green dyes to assess the health of the cornea and conjunctiva.
These dyes highlight areas of damage, inflammation and tear-film instability that may not be visible during a routine examination and provide valuable information about the severity and type of ocular surface disease.
Technology Doesn't Replace Clinical Experience
Although the TERA provides an enormous amount of information, it doesn't diagnose patients on its own.
Every assessment also includes:
A detailed discussion about your symptoms and lifestyle
Review of your medical history and medications
Slit lamp examination
Eyelid assessment
Meibomian gland evaluation
Schirmer's testing where appropriate
Clinical interpretation of all your results
The technology provides objective measurements.
My role is to bring all of those findings together, identify the underlying cause of your symptoms and develop a treatment plan that's right for you.
Seeing Is Understanding
One of my favourite parts of the appointment is reviewing the images with patients.
It's one thing to tell someone they have meibomian gland dysfunction.
It's another to show them.
When patients can see their own meibomian glands, their tear film and the health of their ocular surface, they understand why they're experiencing symptoms and why treatment is recommended.
That understanding often leads to much better engagement with treatment and long-term management.
My Philosophy
I didn't establish The Dry Eye Suite simply to recommend eye drops.
I established it because I believe patients deserve answers.
Every patient deserves to understand:
What type of dry eye they have
Why they have it
Whether it can be treated
How we can protect the health of their eyes in the future
The Topcon TERA is an important part of that journey, helping us move beyond assumptions and make decisions based on objective clinical evidence.
For me, that's what modern dry eye care should look like.
Ready to Understand What's Causing Your Symptoms?
If you've been struggling with dry, watery, burning or irritated eyes, a comprehensive assessment can help identify the underlying cause and guide the most appropriate treatment.
Book your Comprehensive Anterior Eye Assessment today and let us help you understand your eyes—not just your symptoms.